SynOx Therapeutics Revenue and Competitors
Employee Data
- SynOx Therapeutics has 22 Employees.
- SynOx Therapeutics grew their employee count by 38% last year.
SynOx Therapeutics's People
| Name | Title | Email/Phone |
|---|
SynOx Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $22.1M | 50 | -29% | $325.9M | N/A |
#2 | $36.7M | 237 | N/A | N/A | N/A |
#3 | $22.5M | 145 | -1% | N/A | N/A |
#4 | $4.2M | 27 | 13% | N/A | N/A |
#5 | $7.6M | 49 | 11% | N/A | N/A |
#6 | N/A | 22 | 38% | N/A | N/A |
#7 | N/A | 27 | 0% | N/A | N/A |
What Is SynOx Therapeutics?
SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.
keywords:N/A
N/A
Total Funding
22
Number of Employees
N/A
Revenue (est)
38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Dublin City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 28 | 40% | $371M |
#2 | $5.9M | 36 | -38% | N/A |
#3 | N/A | 54 | 74% | N/A |
#4 | N/A | 69 | 30% | N/A |
#5 | N/A | 71 | 29% | N/A |